These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
200 related items for PubMed ID: 35367362
1. MALAT1 enhances gemcitabine resistance in non-small cell lung cancer cells by directly affecting miR-27a-5p/PBOV1 axis. Chen W, Tan X, Yang Q, Fang Z, Xu Y. Cell Signal; 2022 Jun; 94():110326. PubMed ID: 35367362 [Abstract] [Full Text] [Related]
2. LncRNA MALAT1 accelerates non-small cell lung cancer progression via regulating miR-185-5p/MDM4 axis. Wang D, Zhang S, Zhao M, Chen F. Cancer Med; 2020 Dec; 9(23):9138-9149. PubMed ID: 33146951 [Abstract] [Full Text] [Related]
3. Long non-coding RNA MALAT1 regulates proliferation, apoptosis, migration and invasion via miR-374b-5p/SRSF7 axis in non-small cell lung cancer. Song J, Su ZZ, Shen QM. Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1853-1862. PubMed ID: 32141554 [Abstract] [Full Text] [Related]
4. MicroRNA-27a-5p Inhibits Proliferation, Migration, and Invasion and Promotes Apoptosis of Wilms' Tumor Cell by Targeting PBOV1. Guo ZT, Yu Q, Miao C, Ge W, Li P. Mol Cell Biol; 2022 Aug 18; 42(8):e0039721. PubMed ID: 35862727 [Abstract] [Full Text] [Related]
5. LncRNA HCG11 enhances the chemosensitivity of non-small cell lung cancer cells to Gemcitabine via miR-17-5p/p21 axis. Xu Y, Tan X, Yang Q, Fang Z, Chen W. Expert Rev Anticancer Ther; 2024 Aug 18; 24(1-2):81-93. PubMed ID: 38230690 [Abstract] [Full Text] [Related]
6. LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis. Ge P, Cao L, Zheng M, Yao Y, Wang W, Chen X. Exp Mol Pathol; 2021 Jun 18; 120():104633. PubMed ID: 33753110 [Abstract] [Full Text] [Related]
7. LncRNA MALAT1 Depressed Chemo-Sensitivity of NSCLC Cells through Directly Functioning on miR-197-3p/p120 Catenin Axis. Yang T, Li H, Chen T, Ren H, Shi P, Chen M. Mol Cells; 2019 Mar 31; 42(3):270-283. PubMed ID: 30841025 [Abstract] [Full Text] [Related]
8. Long noncoding RNA NORAD acts as a ceRNA mediates gemcitabine resistance in bladder cancer by sponging miR-155-5p to regulate WEE1 expression. Yang Y, Zhang G, Li J, Gong R, Wang Y, Qin Y, Ping Q, Hu L. Pathol Res Pract; 2021 Dec 31; 228():153676. PubMed ID: 34753061 [Abstract] [Full Text] [Related]
9. Long non-coding RNA PRNCR1 modulates non-small cell lung cancer cell proliferation, apoptosis, migration, invasion, and EMT through PRNCR1/miR-126-5p/MTDH axis. Guo R, Hu T, Liu Y, He Y, Cao Y. Biosci Rep; 2020 Jul 31; 40(7):. PubMed ID: 31912882 [Abstract] [Full Text] [Related]
10. Exosome-transmitted circVMP1 facilitates the progression and cisplatin resistance of non-small cell lung cancer by targeting miR-524-5p-METTL3/SOX2 axis. Xie H, Yao J, Wang Y, Ni B. Drug Deliv; 2022 Dec 31; 29(1):1257-1271. PubMed ID: 35467477 [Abstract] [Full Text] [Related]
11. Long noncoding RNA MALAT1 enhances the docetaxel resistance of prostate cancer cells via miR-145-5p-mediated regulation of AKAP12. Xue D, Lu H, Xu HY, Zhou CX, He XZ. J Cell Mol Med; 2018 Jun 31; 22(6):3223-3237. PubMed ID: 29633510 [Abstract] [Full Text] [Related]
12. Long Noncoding RNA MALAT1 Knockdown Inhibits Proliferation, Migration, and Invasion and Promotes Apoptosis in Non-Small-Cell Lung Cancer Cells Through Regulating miR-515-3p/TRIM65 Axis. Wang Y, Zhang Q. Cancer Biother Radiopharm; 2020 Dec 31. PubMed ID: 33395541 [Abstract] [Full Text] [Related]
13. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling. Tang Y, Xiao G, Chen Y, Deng Y. Anticancer Drugs; 2018 Sep 31; 29(8):725-735. PubMed ID: 29916897 [Abstract] [Full Text] [Related]
14. Circ_PIP5K1A regulates cisplatin resistance and malignant progression in non-small cell lung cancer cells and xenograft murine model via depending on miR-493-5p/ROCK1 axis. Feng N, Guo Z, Wu X, Tian Y, Li Y, Geng Y, Yu Y. Respir Res; 2021 Sep 18; 22(1):248. PubMed ID: 34537072 [Abstract] [Full Text] [Related]
15. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC. Jin D, Guo J, Wu Y, Du J, Wang X, An J, Hu B, Kong L, Di W, Wang W. Theranostics; 2019 Sep 18; 9(7):2036-2055. PubMed ID: 31037155 [Abstract] [Full Text] [Related]
16. LncRNA MALAT1 contributes to non-small cell lung cancer progression via modulating miR-200a-3p/programmed death-ligand 1 axis. Wei S, Wang K, Huang X, Zhao Z, Zhao Z. Int J Immunopathol Pharmacol; 2019 Sep 18; 33():2058738419859699. PubMed ID: 31240979 [Abstract] [Full Text] [Related]
17. Circ_0003998 Regulates the Progression and Docetaxel Sensitivity of DTX-Resistant Non-Small Cell Lung Cancer Cells by the miR-136-5p/CORO1C Axis. Zhang W, Song C, Ren X. Technol Cancer Res Treat; 2021 Sep 18; 20():1533033821990040. PubMed ID: 33511909 [Abstract] [Full Text] [Related]
18. Lnc-GAN1 expression is associated with good survival and suppresses tumor progression by sponging mir-26a-5p to activate PTEN signaling in non-small cell lung cancer. Wang RQ, Long XR, Zhou NN, Chen DN, Zhang MY, Wen ZS, Zhang LJ, He FZ, Zhou ZL, Mai SJ, Wang HY. J Exp Clin Cancer Res; 2021 Jan 06; 40(1):9. PubMed ID: 33407724 [Abstract] [Full Text] [Related]
19. Long noncoding HOXA11-AS knockdown suppresses the progression of non-small cell lung cancer by regulating miR-3619-5p/SALL4 axis. Xia H, Niu Q, Ding Y, Zhang Z, Yuan J, Jin W. J Mol Histol; 2021 Aug 06; 52(4):729-740. PubMed ID: 34050851 [Abstract] [Full Text] [Related]
20. Mechanism of METTL14-mediated m6A modification in non-small cell lung cancer cell resistance to cisplatin. Gong S, Wang S, Shao M. J Mol Med (Berl); 2022 Dec 06; 100(12):1771-1785. PubMed ID: 36352154 [Abstract] [Full Text] [Related] Page: [Next] [New Search]